Medical News

RSS

Merck challenges New York jury decision in federal FOSAMAX retrial

Merck & Co., Inc. today said it is challenging the decision returned by a New York jury in the retrial of a federal FOSAMAX case, Boles v. Merck. This case was the Plaintiffs' Steering Committee's top choice to take to trial and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX. The first case to reach a verdict, Maley v. Merck, resulted in a defense verdict for Merck on May 5, 2010.

28 Jun 2010

Saint Thomas Chest Pain Network awarded HRSA grant for placement of AEDs in 14 rural communities

The Saint Thomas Chest Pain Network, a network service provided by Saint Thomas Health Services, was recently awarded a $100,000 Health Resources and Services Administration grant from the United States Department of Health and Human Services for the placement of full-rescue Automated External Defibrillators in 14 rural communities throughout the network.

28 Jun 2010

Roche reports results of 5 taspoglutide Phase III studies for type 2 diabetes at 70th ADA

Ipsen a global biopharmaceutical group, today announced that its partner Roche disclosed results of five Phase III 24-week studies for taspoglutide for type 2 diabetes at the American Diabetes Association's (ADA) 70th Annual Scientific Sessions. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.

28 Jun 2010

Quality Systems’ ad campaign for NextDDS solution earns American Business Award

Quality Systems, Inc. announced today that its Dental Division's NextDDS solution earned the American Business Award (ABA) for best ad campaign in the health products and services category.

28 Jun 2010

Orexigen Therapeutics announces data from CORDiabetes trial for Contrave

Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.

28 Jun 2010

EVISTA improves bone quality as measured by HRpQCT: IIT

Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.

28 Jun 2010

St. Mary Medical Center opens new outpatient center for chronic wound treatment

High Desert residents suffering from hard-to-heal wounds now have greater resources to help heal their wounds and get their lives back. St. Mary Medical Center, a 190-bed acute care hospital in the High Desert of Southern California, announced today the opening of its Center for Wound Care and Hyperbaric Medicine.

28 Jun 2010

Medtronic initiates enrollment in ASPIRE study of MiniMed Paradigm x54 Low Glucose Suspend integrated system

Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.

28 Jun 2010

Early stages of kidney disease in type 1 diabetes can lead to increased risk of death, study author says

People with type 1 diabetes who have early and asymptomatic kidney damage, as indicated by small amounts of protein in the urine, are six times more likely to die compared to the general population, say researchers at the University of Pittsburgh Graduate School of Public Health. Their study, being presented at the 70th Scientific Sessions of the American Diabetes Association, also found that when kidneys remained normal over time, people with type 1 diabetes had no greater risk of death than their healthy counterparts.

28 Jun 2010

Arena's lorcaserin reduces body weight across patient subgroups

Arena Pharmaceuticals, Inc. today reported pooled Week 52 data from more than 6,000 patients in lorcaserin's pivotal Phase 3 clinical trial program that demonstrate lorcaserin 10 mg dosed twice daily reduced body weight in all patient subgroups evaluated, as defined by gender, age, ethnicity and starting body weight and Body Mass Index (BMI). Greater improvements in cardiovascular risk factors were also achieved with lorcaserin treatment compared to placebo overall and in most subgroups.

28 Jun 2010

Transposons create genomic instability and are implicated in cancer and other diseases: Research

Transposons, or "jumping genes," make up roughly half of the human genome. Geneticists previously estimated that they replicate and insert themselves into new locations roughly one in every 20 live births.

28 Jun 2010

Tolerx presents preclinical data on TRX518 anti-GITR immunotherapy for cancer

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.

28 Jun 2010

Report: Health information technology could result in harm to patients without proper monitoring

Health information technology could inadvertently result in harm to patients without proper monitoring, according to a new report by The Leapfrog Group, an employer-backed health advocacy organization.

28 Jun 2010

Helicos BioSciences to develop, market MDx tests that utilize HeliScope Single Molecule Sequencer

Helicos BioSciences Corporation announced today that it is in the early stages of validating molecular diagnostic (MDx) tests that utilize its HeliScope® Single Molecule Sequencer. The HeliScope Sequencer's ability to sequence single molecules of natural, unamplified DNA or RNA simplifies the diagnostic testing workflow obviating the need for the amplification steps utilized by most genetic analysis methods.

28 Jun 2010

Experts to discuss latest trends in treatments, diagnostic techniques for managing HCC

Today, world renowned experts have assembled in Dubrovnik, Croatia to discuss the latest trends in treatment and cutting edge research in diagnostic techniques that will shape the future management of hepatocellular carcinoma - the third most common cause of cancer-related death globally, and a leading cause of death among patients with liver cirrhosis.

28 Jun 2010

In-school education programs can reduce obesity, other risk factors for type 2 diabetes: HEALTHY

Healthier cafeteria choices, longer and more intense periods of physical activity and robust in-school education programs can lower rates of obesity and other risk factors for type 2 diabetes, according to a national study called HEALTHY.

28 Jun 2010

Cardiac MRI helps avoid hospital admissions for chest pain patients

A new study done by researchers at Wake Forest University Baptist Medical Center indicates that chest pain may no longer have to mean a hospital stay - there is another option for diagnosing heart-related chest pain that costs less and, in some cases, allows the patient to return home the same day.

28 Jun 2010

Data shows proportion of total sales from drugs dropped to below 7%

The pharmaceutical industry continues to rely heavily on sales from an aging portfolio of drugs, whilst the proportion of total sales from newer drugs has dropped, according to data released today from the 2010 Pharmaceutical R&D Factbook complied by CMR International, a Thomson Reuters business.

28 Jun 2010

WellPoint research leads to limits on use of Boniva; FDA spars with tobacco company

"WellPoint Inc. (WLP), the largest U.S. managed-care concern by membership, made it harder last year for its members to gain approval for use of the Boniva osteoporosis drug after internal research linked it to higher fracture rates, lower patient compliance and higher total costs of care than two other drugs, a WellPoint executive said Thursday," Dow Jones Newswires/The Wall Street Journal reports.

28 Jun 2010

UNDP, UNAIDS launch Global Commission on HIV, Law

The U.N. Development Program together with UNAIDS on Thursday announced the formation of a commission to examine how legal environments affect HIV/AIDS efforts, VOA News reports (DeCapua, 6/24).

28 Jun 2010

Medical News

Merck challenges New York jury decision in federal FOSAMAX retrial

Saint Thomas Chest Pain Network awarded HRSA grant for placement of AEDs in 14 rural communities

Roche reports results of 5 taspoglutide Phase III studies for type 2 diabetes at 70th ADA

Quality Systems’ ad campaign for NextDDS solution earns American Business Award

Orexigen Therapeutics announces data from CORDiabetes trial for Contrave

EVISTA improves bone quality as measured by HRpQCT: IIT

St. Mary Medical Center opens new outpatient center for chronic wound treatment

Medtronic initiates enrollment in ASPIRE study of MiniMed Paradigm x54 Low Glucose Suspend integrated system

Early stages of kidney disease in type 1 diabetes can lead to increased risk of death, study author says

Arena's lorcaserin reduces body weight across patient subgroups

Transposons create genomic instability and are implicated in cancer and other diseases: Research

Tolerx presents preclinical data on TRX518 anti-GITR immunotherapy for cancer

Report: Health information technology could result in harm to patients without proper monitoring

Helicos BioSciences to develop, market MDx tests that utilize HeliScope Single Molecule Sequencer

Experts to discuss latest trends in treatments, diagnostic techniques for managing HCC

In-school education programs can reduce obesity, other risk factors for type 2 diabetes: HEALTHY

Cardiac MRI helps avoid hospital admissions for chest pain patients

Data shows proportion of total sales from drugs dropped to below 7%

WellPoint research leads to limits on use of Boniva; FDA spars with tobacco company

UNDP, UNAIDS launch Global Commission on HIV, Law

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News